Sensei Biotherapeutics, Inc. - SNSE
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ikarian Capital, LLC | History | Reduced | 21,351 | 227 | 0.02% | 0.02% | 1 | -1,146 | -5.09% | Q4 2025 | Feb 18, 2026 |
| Catalio Capital Management, LP | History | No change | 14,718 | 157 | 0.03% | 0.03% | 2 | 0 | 0.0% | Q4 2025 | Feb 17, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | History | Added to | 11,516 | 122 | 0.0% | 0.0% | 3 | +1,100 | 10.56% | Q4 2025 | Feb 12, 2026 |
| BANK OF AMERICA CORP /DE/ | History | Reduced | 306 | 3 | 0.0% | 0.0% | 4 | -325 | -51.51% | Q4 2025 | Feb 17, 2026 |
| CITIGROUP INC | History | New | 294 | 3 | 0.0% | — | 5 | +294 | New | Q4 2025 | Feb 13, 2026 |
| UBS Group AG | History | Closed out | 0 | 0 | — | 0.0% | — | -873 | -100.0% | Q4 2025 | Jan 29, 2026 |
| SBI Securities Co., Ltd. | History | Reduced | 4 | 0 | — | 0.0% | — | -145 | -97.32% | Q4 2025 | Feb 03, 2026 |
| BNP PARIBAS | History | New | 7 | 0 | — | — | — | +7 | New | Q4 2025 | Feb 10, 2026 |
| JPMORGAN CHASE & CO | History | No change | 32 | 0 | — | — | — | 0 | 0.0% | Q4 2025 | Feb 11, 2026 |
| MORGAN STANLEY | History | No change | 10 | 0 | — | — | — | 0 | 0.0% | Q4 2025 | May 27, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | History | No change | 9 | 0 | — | — | — | 0 | 0.0% | Q4 2025 | Feb 10, 2026 |